Ming Doyle
Comic book illustrator and writer From Wikipedia, the free encyclopedia
Ming Doyle is an American comic book illustrator and writer. Her works, including Anatomy of a Metahuman, have been published by Marvel Comics, DC Comics, and Candlewick Press.[2]
Ming Doyle | |
|---|---|
.jpg) Doyle at HeroesCon 2013 | |
| Born | 1984 (age 40–41) |
| Alma mater | Cornell University |
| Known for | Comics illustration |
| Notable work | Anatomy of a Metahuman, Constantine: The Hellblazer, Two Graves |
| Spouse | [citation needed] |
| Children | 1[1] |
Multiversity Comics praised Doyle's work for its "heavily lined, brushed inks" and the "sense of awe" it creates by "showing superheroics in an otherwise rather realistic setting".[3]
Personal life
Ming Doyle was born in Boston in 1984 to an Irish-American sailor and a Chinese Canadian librarian.[4][5]
In 2007, she graduated from Cornell University with a dual concentration BFA in painting and drawing.[4]
Career
Aside from Marvel, DC, and Candlewick, Doyle's workplaces have included Boom! Studios, Image Comics, Tokyopop,[4] Valiant Comics,[6][7] and Dark Horse Comics.[8]
She describes her 2011 work, Tantalize,[9] as her first full-length graphic novel.[5]
DC universe magician John Constantine's series was relaunched as Constantine: The Hellblazer, written by Doyle and James Tynion IV in June 2015.[10]
The Mary Sue interviewed Doyle in 2015 at Boston Comic Con. She described her life as a freelancer and stated that her dream projects include creating comics about Anne Rice’s Vampire Chronicles; Namor; and Gambit.[11]
In 2018, Doyle illustrated the 160-page DC Comics: Anatomy of a Metahuman, written by S. D. Perry and Matthew K. Manning.[12]
In 2023, she contributed to Two Graves, "the first volume of a new series from writer Genevieve Valentine and illustrated by Annie Wu and Ming Doyle". It was published by Simon & Schuster and also included essays by N.K. Jemisin, Veronica Schanoes, and Stephanie Lai.[13]
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.